0R2M Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 794.8 USD -1.55% Market Closed

Market Cap: $83.5B

	Regeneron Pharmaceuticals Inc LSE:0R2M	US
	Vidrala SA MAD:VID	ES
S	Saul Centers Inc F:SA4	US
G	Green Brick Partners Inc SWB:2G1	US
	Seiko Holdings Corp TSE:8050	JP
	Shell PLC F:L3H	UK
O	Old Dominion Freight Line Inc XBER:ODF	US
V	Vulcan Materials Co DUS:VMC	US
N	NEC Corp SWB:NEC1	JP
T	Tenaris SA XBER:TW11	LU
C	Chefs' Warehouse Inc F:2CF	US
C	Colgate-Palmolive Co XBER:CPA	US
A	AXA SA PAR:CSNV	FR

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Healthy Operating Margin

28%

Sustainable 3Y Average Operating Margin

30%

Declining Operating Margin

36% > 28%

Healthy Net Margin

28%

Strong 3Y Average Net Margin

31%

Declining Net Margin

34% > 28%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

26%

Declining Free Cash Flow Margin

24% > 23%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

16%

Declining ROIC

21% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.